Cargando…
Antibody therapies for treatment of non-severe COVID-19
Autores principales: | Gourlay, Katie, Taylor, Nicholas, Lang, Eddy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923826/ https://www.ncbi.nlm.nih.gov/pubmed/35292911 http://dx.doi.org/10.1007/s11739-022-02959-1 |
Ejemplares similares
-
Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020) -
Perinatal Exposure to High-Fat Diet Programs Energy Balance, Metabolism and Behavior in Adulthood
por: Sullivan, Elinor L., et al.
Publicado: (2011) -
Using mobile sequencers in an academic classroom
por: Zaaijer, Sophie, et al.
Publicado: (2016) -
Cutting Edge: Failure of Antigen-Specific CD4(+) T Cell Recruitment to the Kidney during Systemic Candidiasis
por: Drummond, Rebecca A., et al.
Publicado: (2014) -
Cutting Edge: Circulating Plasmablasts Induce the Differentiation of Human T Follicular Helper Cells via IL-6 Production
por: Chavele, Konstantia-Maria, et al.
Publicado: (2015)